Skip to main content

Table 2 Baseline characteristics of the 43 patients with mild drug-induced hepatotoxicity

From: Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis

 

Patients with hepatoprotective drugs (N = 10)

Patients without hepatoprotective drug (N = 33)

P value

Sex

  

0.80

 Male

7

24

 

 Female

3

9

 

Age (years)

57 ± 21

55 ± 23

0.80

Peak AST (IU/dl)

66 ± 19

58 ± 12

0.20

Peak ALT (IU/dl)

72 ± 21

54 ± 21

0.058

  1. Data are expressed as number or means ± standard error
  2. AST aspartate aminotransferase, ALT alanine aminotransferase